课题基金 / 基金详情

Molecular mechanism of the high incidence of cancer of Bloom's syndrome

Molecular mechanism of the high incidence of cancer of Bloom's syndrome
布卢姆综合征癌症高发的分子机制
批准号:
11138207
负责人:
ENOMOTO Takemi
金额:
$4.8万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 --

项目摘要

项目成果

ENOMOTO Takemi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bloom's syndrome (BS) is a rare genetic disorder and the cells from BS patients show genomic instability and an increased level of sister chromatid exchange (SCE). We analyzed the functions of yeast Sgs 1, which is the yeast homologue for BLM, as well as those of BLM in higher eukaryotic cells and obtained the following results.1. We made mutated SGS1 genes coding a protein having equivalent missense mutations of BS patients and found that none of the mutated genes could suppress the higher sensitivity to MMS and HU and the elevated SCE of sgs 1 disruptants. Analyses of Sgs 1 functions indicated that the two different mechanisms are operated in Sgs 1 functions, one requiring DNA helicase activity and one not. In addition, genetic analyses indicated that Sgs 1 functions in the down stream of Mec 1 and the upstream of Rad 51.2. We generated a monoclonal antibody specifically recognizing BLM protein and using this antibody, found that BLM is localized in speckled structures in the nucleus. We also obtained a piece of evidence indicating that BLM is associated with SUMO-1. Deletion experiments indicated that the amino acid region 238-586 of BLM is required for the localization in speckled structures.3. We generated BLM^<-/-> and BLM^<-/->/RAD54^<-/-> DT40 cells from the chicken B lymphocyte line DT40 and found that SCE and targeted integration frequencies were increased remarkably in BLM^<-/-> cells. The results obtained with BLM^<-/->/RAD54^<-/-> cells indicated that a large portion of the SCE in BLM^<-/-> cells occurs via homologous recombination and more double strand breaks occur during DNA replication in the absence of BLM and some of these breaks are repaired by homologous recombination.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Yasuhiro Matsumoto: "Identification and Immunological Characterization of a Novel 40-kDa Protein Linked to CD98 Antigen"Cell Structure and Function. 24. 217-226 (1999)
Yasuhiro Matsumoto:“与 CD98 抗原相关的新型 40-kDa 蛋白的鉴定和免疫学表征”细胞结构和功能。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shishido, T., Uno, S., Kamohara, M., Tsuneoka-Suzuki, T., Hashimoto, Y., Enomoto, T., and Masuko, T.: "Transformation of Balb3T3 cells caused by overexpression of rat CD98 heavy chain (HC) requires its association with light chain : Missense mutation in a
Shishido, T.、Uno, S.、Kamohara, M.、Tsuneoka-Suzuki, T.、Hashimoto, Y.、Enomoto, T. 和 Masuko, T.:“大鼠 CD98 重链过表达引起的 Balb3T3 细胞转化
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hara, K., Kudoh, H., Enomoto, T., Hashimoto, Y., and Masuko, T.: "Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98."Biochem.Biophys.Res.Commun.. 262. 720-725 (1999)
Hara, K.、Kudoh, H.、Enomoto, T.、Hashimoto, Y. 和 Masuko, T.:“早期淋巴细胞活化抗原 CD98 的过度表达导致 NIH3T3 细胞的恶性转化。”Biochem.Biophys.Res.Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shishido, T., Ohkawa, M., Itoh, A., Enomoto, T., Hashimoto, Y., and Masuko, T.: "Colocalization of GP125/CD98 with tropomyosin isoforms at the cell-cell adhesion boundary."J.Biochem.. (in press).
Shishido, T.、Ohkawa, M.、Itoh, A.、Enomoto, T.、Hashimoto, Y. 和 Masuko, T.:“GP125/CD98 与原肌球蛋白亚型在细胞-细胞粘附边界处的共定位。”J
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Analyses of function of RecQ helicase and its related proteins and detection of endogenous DNA damaging agents
    • 批准号:
      26440065
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2014
    • 负责人:
      ENOMOTO Takemi
    • 依托单位:
    Functions of RECQL1 and RECQL5 in the maintenance of genome stability
    • 批准号:
      23370065
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.73万
    • 财政年份:
      2011
    • 负责人:
      ENOMOTO Takemi
    • 依托单位:
    Study on the functions of WRN and WRNIP1 that interacts with WRN
    • 批准号:
      20390020
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2008
    • 负责人:
      ENOMOTO Takemi
    • 依托单位:
    Studies on the function of Werner syndrome gene product and analyses of the mechanism to induce aging related symptoms
    • 批准号:
      18390019
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.7万
    • 财政年份:
      2006
    • 负责人:
      ENOMOTO Takemi
    • 依托单位:
    国内基金
    海外基金
    牛磺胆酸通过靶向抑制BLM乳酸化修饰调控DNA同源重组修复逆转蒽环类化疗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李心远
    • 依托单位:
    BLM解旋酶抑制剂纳米马达智能给药系统构建及对前列腺癌的协同治疗作用
    • 批准号:
      82360558
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      陈琨
    • 依托单位:
    BLM DNA解旋酶作为抑制三阴性乳腺癌多倍体巨瘤细胞增殖和耐药作用靶点的分子调控机制研究
    • 批准号:
      --
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      33万元
    • 批准年份:
      2022
    • 负责人:
      刘杰麟
    • 依托单位:
    新型重组减毒沙门菌介导沉默BLM基因抗胃癌作用的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2021
    • 负责人:
      王新友
    • 依托单位: